Skip to content

Study on the identification of mirror therapy non-responders in stroke patients and brain function remodeling mechanism combined with repetitive transcranial magnetic stimulation

Study on the identification of mirror therapy non-responders in stroke patients and brain function remodeling mechanism combined with repetitive transcranial magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060550
Enrollment
Unknown
Registered
2022-06-04
Start date
2022-05-30
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

N/A(Phase 1):Mirror therapy
MT non-responders Group A(Phase 2):rTMS combined with MT
MT non-responders Group B(Phase 2):Sham rTMS combined with MT
MT responders Group A(Phase 2):rTMS combined with MT
MT responders Group B(Phase 2):Sham rTMS combined with MT

Sponsors

Fifth Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the stroke diagnostic criteria set by the fourth National Academic Conference on Cerebrovascular Diseases; 2. Confirmed as ischemic stroke by CT or MRI, with a course of disease over 6 months; 3. Hemiplegia after stroke, with Brunnstrom stage of 1–3; 4. Montreal Cognitive Assessment (MoCA) score >=21; 5. 50-75 years old; 6. Right-handedness; 7. Voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous medical history of upper limb fracture, upper limb deformity, etc; 2. Unstable condition or change in patients condition occurred during the experiment, affecting the experimental results; 3. Cannot complete the experiment because of severe heart, lung, liver and kidney and other important organ diseases; 4. Severe cognitive dysfunction or aphasia; 5. Has severe mental disorder; 6. Taking medication that lower the seizure threshold; 7. Patients with contraindications to rTMS.

Design outcomes

Primary

MeasureTime frame
Oxygenated hemoglobin concentration in the brain region of interest;Motor evoked potential;Surface electromyography;

Secondary

MeasureTime frame
Montreal Cognitive Assessment;Fugl-Meyer assessment-upper limb;Action Research Arm test;

Countries

China

Contacts

Public ContactQiu Yaxian

Fifth Affiliated Hospital of Guangzhou Medical University

2017687049@gzhmu.edu.cn+86 13580469269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026